- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06186882
Gene x Environment Interplay in Developmental Dyslexia Treatment: A Round-trip Translation Between Humans and Animal (Gedys)
December 15, 2023 updated by: IRCCS Eugenio Medea
Developmental dyslexia affects 7% of school-age children (Male:Female ratio of 1.5:1) and incurs disadvantages in education and occupation.
Scientific progress concerning the etiology of developmental dyslexia evidenced the complex gene-environment interaction.
The DCDC2-READ1 deletion associates with reading skills and affects the magnocellular-dorsal stream in humans and animals.
DCDC2 modifies neural activity within the excitatory pathways.
The magnocellular-dorsal stream mediates the function of the attention network.
Difficulties in spatial and temporal attention shifting impair letter-to-speech sound integration increasing neural noise.
Action video games improve the efficiency of the magnocellular-dorsal stream.
The aim of this cutting-edge, round trip translation study is threefold: 1.to unravel new insights behind the pathophysiology of developmental dyslexia, 2. to assess gene-environment interaction effects on developmental dyslexia endophenotypes, and 3. to identify useful clues to foster the identification of new, personalized treatments.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sara Mascheretti
- Phone Number: 031877895
- Email: sara.mascheretti@lanostrafamiglia.it
Study Locations
-
-
LC
-
Bosisio Parini, LC, Italy, 23842
- Recruiting
- Scientific Institute IRCCS E Medea
-
Contact:
- Sara Mascheretti
- Phone Number: 031877985
- Email: sara.mascheretti@lanostrafamiglia.it
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria
- 5-years old pre-readers,
- normal intelligence quotient,
- no main counter indications for magnetic resonance acquisition,
- no previous diagnosis of any neurodevelopmental disorders.
Exclusion Criteria:
- intelligence quotient below the average range,
- presence of counter indications for magnetic resonance acquisition,
- previous diagnosis of any neurodevelopmental disorders.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: ENVIRONMENTAL STIMULATION
|
Thanks to their specific characteristics (presentation of multiple peripheral, rapidly moving, spatio-temporally unpredictable stimuli), Action Video-Games improve reading skills through their effects on the Magnocellular-Dorsal stream.
Training will consist of 20 days of Action Video-Games sessions of 1 hour each, three times per week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Short-term memory
Time Frame: 3 years
|
Short-term memory - assessed by the Single Digit Forward Span, Single Digit Backward Span.
Measures obtained: Z scores age-corrected.
|
3 years
|
|
Phonological awareness
Time Frame: 3 years
|
Phonological awareness - assessed by the nonword repetition test.
Measures obtained: Z scores age-corrected.
|
3 years
|
|
Rapid automatized naming
Time Frame: 3 years
|
Rapid automatized naming - assessed by the RAN test.
Measures obtained: Z scores age-corrected.
|
3 years
|
|
Reading skills
Time Frame: 3 years
|
Reading skills - assessed by single unrelated words and pseudo-words reading tests.
Measures obtained: Z scores age-corrected.
|
3 years
|
|
Visual attention
Time Frame: 3 years
|
Visual attention - assessed by a computer-based visual attention task
|
3 years
|
|
Visual motion processing
Time Frame: 3 years
|
Visual motion processing - assessed by Coherent dot motion task
|
3 years
|
|
measurement of neurotransmitters
Time Frame: 3 years
|
in vivo measures of neurotransmitters including glutamate and gamma-Aminobutyric acid magnetic resonance spectroscopy
|
3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 30, 2023
Primary Completion (Estimated)
April 30, 2026
Study Completion (Estimated)
April 30, 2026
Study Registration Dates
First Submitted
November 30, 2023
First Submitted That Met QC Criteria
December 15, 2023
First Posted (Estimated)
January 1, 2024
Study Record Updates
Last Update Posted (Estimated)
January 1, 2024
Last Update Submitted That Met QC Criteria
December 15, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GR-2021-12375102
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Reading Disorder
-
University of Heidelberg Medical CenterUnknownDyslexia | Reading Disability | Reading Disorder | Developmental Reading DisorderGermany
-
Federal University of São PauloConselho Nacional de Desenvolvimento Científico e Tecnológico; Instituto ABCDUnknownDifficult; Spelling, With Reading DisorderBrazil
-
Aix Marseille UniversitéUniversity of Roma La Sapienza; WHO Collaborating Centre for Maternal and Child...CompletedReading Disability
-
Stanford UniversityActive, not recruiting
-
Sherine TambyrajaOhio State UniversityCompleted
-
The University of Texas Health Science Center,...Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAttention Deficit Hyperactivity Disorder | Reading DisabilitiesUnited States
-
University of CopenhagenCompleted
-
University of Sao PauloCompleted
-
Ohio State UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingReading DifficultiesUnited States
-
State University of New York at BuffaloCompletedReading ProblemUnited States
Clinical Trials on Action Video-Game
-
The Hong Kong Polytechnic UniversityUniversity of California, Berkeley; University of WaterlooCompletedVision, Balance and Falls in Older AdultsChina
-
University of Wisconsin, MadisonBrain & Behavior Research FoundationCompleted
-
Brigham Young UniversityCompleted
-
Universidad Nacional de Educación a DistanciaCompleted
-
San Francisco Veterans Affairs Medical CenterVA Office of Research and DevelopmentCompletedTBI (Traumatic Brain Injury)United States
-
Universitat Politècnica de CatalunyaCompleted
-
Yale UniversityCompleted
-
Anne KloosCompletedHuntington's DiseaseUnited States
-
Université Blaise Pascal, Clermont-FerrandWithdrawnPassive Video Games (PVG) | Active Video Games (AVG) | Exercise (EX)France